Explore News
-
Why Novo and Lilly are Racing for GLP-1 Supremacy
Novo Nordisk and Eli Lilly rivalry intensifies in GLP-1 pill market
-
Ozempic Reveals Promising Weight Loss Results in Seniors
Semaglutide shows significant weight loss in adults over 65
-
9 in 10 Patients Report Reduced Food Noise on GLP-1s
As GLP-1 drugs silence relentless food cravings, scientists race to understand the mental chatter that…
-
Why Retatrutide Is Being Touted as a Game-Changer
Retatrutide, an injectable peptide, shows promise in clinical trials
-
Why Are Weight-Loss Jabs Linked to Gallbladder Issues?
Surgeons call for research into potential link between weight-loss injections and rising gallbladder removals
-
NHS to Offer Weight-Loss Injections to Over 1 Million at Risk of Heart Attacks
Groundbreaking treatment aims to reduce risk of further heart attacks and strokes
